| Future of neuropeptides in biological psychiatry and emotional psychopharmacology: Goals and strategies. J Panksepp, J Harro Wiley-Liss, 2004 | 358 | 2004 |
| The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y A Kask, J Harro, S von Hörsten, JP Redrobe, Y Dumont, R Quirion Neuroscience & Biobehavioral Reviews 26 (3), 259-283, 2002 | 347 | 2002 |
| CCK in animal and human research on anxiety J Harro, E Vasar, J Bradwejn Trends in pharmacological sciences 14 (6), 244-249, 1993 | 308 | 1993 |
| Objectively measured physical activity and sedentary time during childhood, adolescence and young adulthood: a cohort study FB Ortega, K Konstabel, E Pasquali, JR Ruiz, A Hurtig-Wennlöf, J Mäestu, ... PloS one 8 (4), e60871, 2013 | 299 | 2013 |
| Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus J Harro, L Oreland Brain Research Reviews 38 (1-2), 79-128, 2001 | 207 | 2001 |
| Autoantibodies against neuropeptides are associated with psychological traits in eating disorders SO Fetissov, J Harro, M Jaanisk, A Järv, I Podar, J Allik, I Nilsson, ... Proceedings of the National Academy of Sciences 102 (41), 14865-14870, 2005 | 150 | 2005 |
| Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide α-MSH, at the origin of eating disorders N Tennoune, P Chan, J Breton, R Legrand, YN Chabane, K Akkermann, ... Translational psychiatry 4 (10), e458-e458, 2014 | 138 | 2014 |
| Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1‐selective antagonist BIBP3226 A Kask, L Rägo, J Harro British journal of pharmacology 124 (7), 1507-1515, 1998 | 136 | 1998 |
| Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1 AL Garcia-Garcia, N Elizalde, D Matrov, J Harro, SM Wojcik, E Venzala, ... Biological psychiatry 66 (3), 275-282, 2009 | 132 | 2009 |
| Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry J Harro, M Tõnissaar, M Eller, A Kask, L Oreland Brain research 899 (1-2), 227-239, 2001 | 130 | 2001 |
| Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics J Harro, RA Kiivet, A Lang, E Vasar Behavioural brain research 39 (1), 63-71, 1990 | 129 | 1990 |
| Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing M Paaver, N Nordquist, J Parik, M Harro, L Oreland, J Harro Psychopharmacology 194 (4), 545-554, 2007 | 125 | 2007 |
| Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment J Harro, R Häidkind, M Harro, AR Modiri, PG Gillberg, R Pähkla, V Matto, ... European Neuropsychopharmacology 10 (1), 5-16, 1999 | 116 | 1999 |
| Platelet monoamine oxidase in healthy 9-and 15-years old children: the effect of gender, smoking and puberty. M Harro, D Eensoo, E Kiive, L Merenäkk, J Alep, L Oreland, J Harro Progress in neuro-psychopharmacology & biological psychiatry 25 (8), 1497-1511, 2001 | 114 | 2001 |
| Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression, and extracellular levels of dopamine T Mällo, A Alttoa, K Kõiv, M Tõnissaar, M Eller, J Harro Behavioural brain research 177 (2), 269-281, 2007 | 112 | 2007 |
| Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat J Harro, E Vasar European journal of pharmacology 193 (3), 379-381, 1991 | 109 | 1991 |
| Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment J Harro, M Põld, E Vasar Naunyn-Schmiedeberg's archives of pharmacology 341 (1), 62-67, 1990 | 107 | 1990 |
| Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13–36 microinjected into vicinity of locus coeruleus in rats A Kask, L Rägo, J Harro Brain research 788 (1-2), 345-348, 1998 | 104 | 1998 |
| Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam A Kask, L Rägo, J Harro European journal of pharmacology 317 (2-3), R3-R4, 1996 | 99 | 1996 |
| Improvements in fitness reduce the risk of becoming overweight across puberty FB Ortega, I Labayen, JR Ruiz, E Kurvinen, HM Loit, J Harro, ... Medicine and science in sports and exercise 43 (10), 1891-1897, 2011 | 95 | 2011 |
